Clinical Trial: A Prospective, Multicenter, Randomized, Parallel-Controlled Superiority Study Evaluating the Efficacy and Safety of a Transcatheter Intramyocardial Septal Radiofrequency Ablation System in Patients With Obstructive Hypertrophic Cardiomyopathy (China)

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Multicenter, Randomized, Parallel-Controlled Superiority Study Evaluating the Efficacy and Safety of a Transcatheter Intramyocardial Septal Radiofrequency Ablation System in Patients With Obstructive Hypertrophic Cardiomyopathy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134002

Registration Time: 2026/10/10

Type: Interventional study

Primary Sponsor: Capital Medical University Affiliated Beijing Anzhen Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=275525

Published by HT Digital Content Services with permission from Health...